These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7628983)

  • 21. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids.
    Guiney DG; Hasegawa P; Davis CE
    Plasmid; 1984 May; 11(3):248-52. PubMed ID: 6379711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactate dehydrogenase activity in Bacteroides fragilis group strains with induced resistance to metronidazole.
    Presečki Stanko A; Sóki J; Varda Brkić D; Plečko V
    J Glob Antimicrob Resist; 2016 Jun; 5():11-4. PubMed ID: 27436459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and expression of the Bacteroides fragilis TAL2480 neuraminidase gene, nanH, in Escherichia coli.
    Russo TA; Thompson JS; Godoy VG; Malamy MH
    J Bacteriol; 1990 May; 172(5):2594-600. PubMed ID: 2158974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial synergy in mixed aerobic/anaerobic infections.
    Ingham HR; Selkon JB; Sisson PR; Middleton RL
    Lancet; 1980 Mar; 1(8169):659-60. PubMed ID: 6102668
    [No Abstract]   [Full Text] [Related]  

  • 27. Incomplete anaerobiosis as a cause of metronidazole 'resistance'.
    Milne SE; Stokes EJ; Waterworth PM
    J Clin Pathol; 1978 Oct; 31(10):933-5. PubMed ID: 213449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of activity of metronidazole by Escherichia coli under sub-optimal anaerobic conditions.
    Ingham HR; Sisson PR; Eisenstadt RL; Sprott MS; Byrne PO; Selkon JB
    J Antimicrob Chemother; 1981 Dec; 8(6):475-9. PubMed ID: 7037728
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugal transfer of antibiotic resistance factors in Bacteroides fragilis: the btgA and btgB genes of plasmid pBFTM10 are required for its transfer from Bacteroides fragilis and for its mobilization by IncP beta plasmid R751 in Escherichia coli.
    Hecht DW; Jagielo TJ; Malamy MH
    J Bacteriol; 1991 Dec; 173(23):7471-80. PubMed ID: 1657890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant.
    Diniz CG; Farias LM; Carvalho MA; Rocha ER; Smith CJ
    J Antimicrob Chemother; 2004 Jul; 54(1):100-8. PubMed ID: 15150173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in transformation of repair-deficient mutants of E. coli with BPDE- or chlorozotocin-modified plasmid DNA.
    Vadi HV
    Carcinogenesis; 1983 Nov; 4(11):1379-84. PubMed ID: 6227422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of cefotaxime and metronidazole against bacteroides and Escherichia coli alone and in mixed culture.
    Soriano F; Ponte C; Santamaría M
    J Antimicrob Chemother; 1983 Jul; 12(1):89-92. PubMed ID: 6311784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial expression levels of nimA are decisive for protection against metronidazole in Bacteroides fragilis.
    Kupc M; Paunkov A; Strasser D; Sóki J; Leitsch D
    Anaerobe; 2022 Oct; 77():102630. PubMed ID: 36028117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
    Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
    J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
    [No Abstract]   [Full Text] [Related]  

  • 37. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation spectra analysis suggests that N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-induced lesions are subject to transcription-coupled repair in Escherichia coli.
    Iannone R; Inga A; Luque-Romero FL; Menichini P; Abbondandolo A; Abril N; Pueyo C; Fronza G
    Mol Carcinog; 1997 May; 19(1):39-45. PubMed ID: 9180927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of the Escherichia coli mutT mutator allele in an anaerobic environment.
    Fowler RG; Erickson JA; Isbell RJ
    J Bacteriol; 1994 Dec; 176(24):7727-9. PubMed ID: 8002599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.